Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice
Jiaqi Li, Zherui Zhang, Hongqing Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 415
The landscape of mRNA nanomedicine
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 312
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
Alexandra Suberi, Molly K. Grun, Tianyang Mao, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 709
Open Access | Times Cited: 85
Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape
Xiang Li, Jing Qi, Juan Wang, et al.
Theranostics (2024) Vol. 14, Iss. 2, pp. 738-760
Open Access | Times Cited: 30
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 23
Rise of the RNA machines – self-amplification in mRNA vaccine design
Jerôme D.G. Comes, Gorben P. Pijlman, Tessy A. H. Hick
Trends in biotechnology (2023) Vol. 41, Iss. 11, pp. 1417-1429
Open Access | Times Cited: 42
Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19
Noelia Silva-Pilipich, Uxue Beloki, Laura Salaberry, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 318-318
Open Access | Times Cited: 9
Lipid Nanoparticle Delivery of Chemically Modified NGFR100W mRNA Alleviates Peripheral Neuropathy
Xiang Yu, Zheng Yang, Yu Zhang, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 3
Closed Access | Times Cited: 23
Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
Yuxiang Zhao, Linchuan Gan, Dangjin Ke, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer
Yuanyuan Liu, Fengyang He, Longming Chen, et al.
Small (2024)
Closed Access | Times Cited: 6
Delivery of mRNA Using Biomimetic Vectors: Progress and Challenges
Menghao Yin, Hanruo Sun, Yanan Li, et al.
Small (2024) Vol. 20, Iss. 43
Closed Access | Times Cited: 5
Development and application of ribonucleic acid therapy strategies against COVID-19
Lin Ning, Mujiexin Liu, Yushu Gou, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 5070-5085
Open Access | Times Cited: 22
The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19
Aline Almeida-Oliveira, Diana Freire, A. Andrade, et al.
Journal of Pharmaceutical Innovation (2023) Vol. 18, Iss. 3, pp. 1194-1212
Open Access | Times Cited: 12
The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects
Craig Collins, Dan L. Longo, William J. Murphy
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Messenger RNA-encoded antibody approach for targeting extracellular and intracellular tau
Patricia Wongsodirdjo, Alayna C Caruso, Alicia Yong, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 3
Efficacy and safety of an mRNA encoding neutralizing antibody against SARS-CoV-2 in non-human primates
Hang Chi, Suo-Qun Zhao, Yunpeng Liu, et al.
Science Bulletin (2025)
Closed Access
Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer
Lirui Tang, Haiying Que, Yuquan Wei, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Delivery platforms for broadly neutralizing antibodies
Lok R. Joshi, Nicolás M. S. Gálvez, Sukanya Ghosh, et al.
Current Opinion in HIV and AIDS (2023)
Open Access | Times Cited: 6
Animal models for studying coronavirus infections and developing antiviral agents and vaccines
Qisheng Lin, Chunni Lu, Yuqi Hong, et al.
Antiviral Research (2022) Vol. 203, pp. 105345-105345
Open Access | Times Cited: 9
Respiratory delivered vaccines: Current status and perspectives in rational formulation design
Lan Wu, Wenwen Xu, Huiyang Jiang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5132-5160
Open Access | Times Cited: 1
Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster
Yanan Zhang, Hongqing Zhang, Guifeng Wang, et al.
Antiviral Research (2022) Vol. 209, pp. 105507-105507
Open Access | Times Cited: 5
Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice
Huijie Yang, Ying Xie, Shuyan Li, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Application of self-amplifying mRNA technology in the development of infectious disease vaccines
Xiaodan Li, Xin Wang, Bo Zhang
Chinese Science Bulletin (Chinese Version) (2023) Vol. 69, Iss. 33, pp. 4889-4904
Closed Access | Times Cited: 1
The Use of Animal Models for Antiviral Therapeutics Development: Opportunities and Challenges
Islam Abbadi, Mustapha Lkhider, Ahd Ouladlahsen, et al.
Livestock diseases and management (2024), pp. 255-286
Closed Access
Cancer therapy via neoepitope-specific monoclonal antibody cocktails
Colin J. Hartman, Asmaa O. Mohamed, Girja S. Shukla, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top